ENZO BIOCHEM INC. COMMON STOCK ($0.01 PAR VALUE)
0.7101
30-December-24 09:51:40
15 minutes delayed
Stocks
-0.0179
-2.46%
Today's range
0.6913 - 0.7280
ISIN
N/A
Source
NYSE
-
Enzo Biochem Reports Third Quarter Fiscal Year 2023 Financial Results
14 Jun 2023 19:21:53 By Nasdaq GlobeNewswire
-
Enzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset Sale
22 May 2023 09:20:00 By Nasdaq GlobeNewswire
-
Enzo Biochem, Inc. Announces Date of Special Meeting of Shareholders
24 Apr 2023 16:05:00 By Nasdaq GlobeNewswire
-
Enzo Biochem Reports Second Quarter Fiscal Year 2023 Financial Results
21 Mar 2023 09:43:27 By Nasdaq GlobeNewswire
-
Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp
16 Mar 2023 16:30:00 By Nasdaq GlobeNewswire
-
Enzo Biochem Reports First Quarter Fiscal Year 2023 Financial Results and Provides Business Update
12 Dec 2022 17:29:13 By Nasdaq GlobeNewswire
-
07 Dec 2022 18:18:10 By Nasdaq GlobeNewswire
-
Enzo Biochem, Inc. Announces Date of Annual Shareholders’ Meeting
08 Nov 2022 18:04:48 By Nasdaq GlobeNewswire
-
Enzo Biochem, Inc. Appoints Patricia Eckert, CPA as Interim CFO
20 Oct 2022 08:15:00 By Nasdaq GlobeNewswire
-
14 Oct 2022 07:30:00 By Nasdaq GlobeNewswire
-
10 Oct 2022 11:31:11 By Nasdaq GlobeNewswire
-
06 Oct 2022 08:00:02 By Nasdaq GlobeNewswire
-
26 Sep 2022 08:00:01 By Nasdaq GlobeNewswire
-
Enzo Biochem to Launch Monkeypox Testing Services this Week
11 Aug 2022 08:00:01 By Nasdaq GlobeNewswire
-
Enzo Biochem Appoints Matthew Kupferberg as General Counsel
03 Aug 2022 08:00:01 By Nasdaq GlobeNewswire
-
09 Jun 2022 16:30:00 By Nasdaq GlobeNewswire
-
06 Jun 2022 08:30:00 By Nasdaq GlobeNewswire
-
02 Jun 2022 17:05:00 By Nasdaq GlobeNewswire
-
Enzo Biochem Announces New York State Department of Health Approval of HPV Molecular Diagnostic Test
19 Apr 2022 08:00:01 By Nasdaq GlobeNewswire
-
Enzo Biochem Reports Results of its Annual Meeting of Shareholders
12 Apr 2022 08:30:01 By Nasdaq GlobeNewswire